Page 383 - Read Online
P. 383

Mura et al.                                                                                                                                                                            The peritoneal metastases from GC

               intraperitoneal chemotherapy: a single western center experience. Eur   G,  Körber  J,  Krause  BJ,  Kuhn  C,  Kullmann  F,  Lang  H,  Link  H,
               J Surg Oncol 2008;34:1246-52.                     Lordick F, Ludwig K, Lutz M, Mahlberg R, Malfertheiner P, Merkel
           54.  Glehen  O,  Gilly  FN, Arvieux  C,  Cotte  E,  Boutitie  F,  Mansvelt  B,   S, Messmann H, Meyer HJ, Mönig S, Piso P, Pistorius S, Porschen R,
               Bereder JM, Lorimier G, Quenet F, Elias D; Association Française   Rabenstein T, Reichardt P, Ridwelski K, Röcken C, Roetzer I, Rohr
               de Chirurgie. Peritoneal carcinomatosis from gastric cancer: a multi-  P, Schepp W, Schlag PM, Schmid RM, Schmidberger H, Schmiegel
               institutional  study  of  159  patients  treated  by  cytoreductive  surgery   WH, Schmoll HJ, Schuch G, Schuhmacher C, Schütte K, Schwenk
               combined with perioperative intraperitoneal chemotherapy. Ann Surg   W, Selgrad M, Sendler A, Seraphin J, Seufferlein T, Stahl M, Stein
               Oncol 2010;17:2370-7.                             H, Stoll C, Stuschke M, Tannapfel A, Tholen R, Thuss-Patience P,
           55.  Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, Cheng FL, Zhou YF,   Treml K, Vanhoefer U, Vieth M, Vogelsang H, Wagner D, Wedding
               Xiong B, Yonemura Y, Li Y. Cytoreductive surgery and hyperthermic   U, Weimann A, Wilke H, Wittekind C; AWMF; AWMF. German S3-
               intraperitoneal  chemotherapy  improves  survival  of  patients  with   guideline  “Diagnosis and treatment  of esophagogastric  cancer”.  Z
               peritoneal carcinomatosis from gastric cancer: final results of a phase   Gastroenterol 2011;49:461-531.
               III randomized clinical trial. Ann Surg Oncol 2011;18:1575-81.  66.    Glehen  O,  Passot  G,  Villeneuve  L,  Vaudoyer  D,  Bin-Dorel  S,
           56.  Magge D, Zenati M, Mavanur A, Winer J, Ramalingam L, Jones H,   Boschetti  G,  Piaton  E,  Garofalo  A.  GASTRICHIP:  D2  resection
               Zureikat A,  Holtzman  M,  Lee  K, Ahrendt  S,  Pingpank  J,  Zeh  HJ,   and hyperthermic intraperitoneal chemotherapy in locally advanced
               Bartlett DL, Choudry HA. Aggressive locoregional surgical therapy for   gastric carcinoma: a randomized and multicenter phase III study. BMC
               gastric peritoneal carcinomatosis. Ann Surg Oncol 2014;21:1448-55.  Cancer 2014;14:183.
           57.  Rudloff  U,  Langan  RC,  Mullinax  JE,  Beane  JD,  Steinberg  SM,   67.   Roviello F, Caruso S, Neri A, Marrelli D. Treatment and prevention
               Beresnev T, Webb CC, Walker M, Toomey MA, Schrump D, Pandalai   of  peritoneal  carcinomatosis  from  gastric  cancer  by  cytoreductive
               P, Stojadinovic A, Avital I. Impact of maximal cytoreductive surgery   surgery  and  hyperthermic  intraperitoneal  chemotherapy:  overview
               plus regional  heated  intraperitoneal  chemotherapy  (HIPEC) on   and rationale. Eur J Surg Oncol 2013;39:1309-16.
               outcome of patients with peritoneal carcinomatosis of gastric origin:   68.  Canbay  E,  Yonemura  Y,  Brucher  B,  Baik  SH,  Sugarbaker  PH.
               results of the GYMSSA trial. J Surg Oncol 2014;110:275-84.  Intraperitoneal chemotherapy and its evolving role in management
           58.  Glehen  O,  Gilly  FN,  Boutitie  F,  Bereder  JM,  Quenet  F,  Sideris   of  gastric  cancer  with  peritoneal  metastases.  Chin  J  Cancer  Res
               L,  Mansvelt  B,  Lorimier  G,  Msika  S,  Elias  D;  French  Surgical   2014; 26:1-3.
               Association. Toward curative treatment of peritoneal carcinomatosis   69.  Heiss  MM,  Murawa  P,  Koralewski  P,  Kutarska  E,  Kolesnik  OO,
               from  nonovarian  origin  by  cytoreductive  surgery  combined  with   Ivanchenko VV,  Dudnichenko AS, Aleknaviciene  B,  Razbadauskas
               perioperative  intraperitoneal  chemotherapy:  a  multi-institutional   A, Gore M, Ganea-Motan E, Ciuleanu T, Wimberger P, Schmittel A,
               study of 1,290 patients. Cancer 2010;116:5608-18.  Schmalfeldt B, Burges A, Bokemeyer C, Lindhofer H, Lahr A, Parsons
           59.  Al-Shammaa HA, Li  Y,  Yonemura  Y. Current status and future   SL.  The  trifunctional  antibody  catumaxomab  for  the  treatment  of
               strategies of cytoreductive surgery plus intraperitoneal hyperthermic   malignant ascites due to epithelial cancer: Results of a prospective
               chemotherapy for peritoneal carcinomatosis. World J Gastroenterol   randomized phase II/III trial. Int J Cancer 2010;127:2209-21.
               2008;14:1159-66.                               70.  Goéré D, Gras-Chaput N, Aupérin A, Flament C, Mariette C, Glehen O,
           60.  Fujimoto  S,  Takahashi  M,  Mutou  T,  Kobayashi  K,  Toyosawa  T.   Zitvogel L, Elias D. Treatment of gastric peritoneal carcinomatosis by
               Successful intraperitoneal  hyperthermic  chemoperfusion for the   combining complete surgical resection of lesions and intraperitoneal
               prevention  of  postoperative  peritoneal  recurrence  in  patients  with   immunotherapy using catumaxomab. BMC Cancer 2014;14:148.
               advanced gastric carcinoma. Cancer 1999;85:529-34.  71.  Bando E, Yonemura Y, Takeshita Y, Taniguchi K, Yasui T, Yoshimitsu
           61.  Yonemura  Y,  de  Aretxabala  X,  Fujimura  T,  Fushida  S,  Katayama   Y, Fushida S, Fujimura T, Nishimura G, Miwa K. Intraoperative lavage
               K,  Bandou  E,  Sugiyama  K,  Kawamura  T,  Kinoshita  K,  Endou  Y,   for cytological examination in 1,297 patients with gastric carcinoma.
               Sasaki T. Intraoperative chemohyperthermic peritoneal perfusion as   Am J Surg 1999;178:256-62.
               an adjuvant to gastric cancer: final results of a randomized controlled   72.  Makino T, Fujiwara Y, Takiguchi S, Miyata H, Yamasaki M, Nakajima
               study. Hepatogastroenterology 2001;48:1776-82.    K, Nishida T, Mori M, Doki Y. The utility of pre-operative peritoneal
           62.  Yan TD,  Black  D,  Sugarbaker  PH,  Zhu  J, Yonemura Y,  Petrou  G,   lavage examination in serosa-invading gastric cancer patients. Surgery
               Morris DL. A systematic review and meta-analysis of the randomized   2010;148:96-102.
               controlled  trials  on  adjuvant  intraperitoneal  chemotherapy  for   73.  Roviello  F,  Marrelli  D,  de  Manzoni  G,  Morgagni  P,  Di  Leo  A,
               resectable gastric cancer. Ann Surg Oncol 2007;14:2702-13.  Saragoni L, De Stefano A; Italian Research Group for Gastric Cancer.
           63.  Sun J, Song Y, Wang Z, Gao P, Chen X, Xu Y, Liang J, Xu H. Benefits   A prospective study of peritoneal recurrence after curative surgery for
               of  hyperthermic  intraperitoneal  chemotherapy  for  patients  with   gastric cancer. Br J Surg 2003;90:1113-9.
               serosal invasion in gastric cancer: a meta-analysis of the randomized   74.  Bonenkamp JJ, Songun I, Hermans J, van de Velde CJ. Prognostic
               controlled trials. BMC Cancer 2012;12:526.        value  of  positive  cytology  findings  from  abdominal  washings  in
           64.  Coccolini  F,  Cotte  E,  Glehen  O,  Lotti  M,  Poiasina  E,  Catena  F,   patients with gastric cancer. Br J Surg 1996;83:672-4.
               Yonemura Y, Ansaloni L. Intraperitoneal chemotherapy in advanced   75.  Edge  S.  Cancer AJCo: AJCC  cancer  staging  manual.  7th  ed.  New
               gastric cancer. Meta-analysis of randomized trials. Eur J Surg Oncol   York: Springer, 2010.
               2014;40:12-26.                                 76.  Allum  WH,  Blazeby  JM,  Griffin  SM,  Cunningham  D,  Jankowski
           65.  Moehler M, Al-Batran SE, Andus T, Anthuber M, Arends J, Arnold   JA,  Wong  R.  Association  of  Upper  Gastrointestinal  Surgeons  of
               D, Aust  D,  Baier  P,  Baretton  G,  Bernhardt  J,  Boeing  H,  Böhle  E,   Great  Britain  and  Ireland,  the  British  Society  of  Gastroenterology
               Bokemeyer C, Bornschein J, Budach W, Burmester E, Caca K, Diemer   and the British Association of Surgical Oncology. Guidelines for the
               WA, Dietrich CF, Ebert M, Eickhoff A, Ell C, Fahlke J, Feussner H,   management of oesophageal and gastric cancer. Gut 2011;60:1449-72.
               Fietkau R, Fischbach W, Fleig W, Flentje M, Gabbert HE, Galle PR,   77.  Fujiwara Y, Doki Y, Taniguchi H, Sohma I, Takiguchi S, Miyata H,
               Geissler M, Gockel I, Graeven U, Grenacher L, Gross S, Hartmann   Yamasaki M, Monden M. Genetic detection of free cancer cells in the
               JT, Heike M, Heinemann V, Herbst B, Herrmann T, Höcht S, Hofheinz   peritoneal cavity of the patient with gastric cancer: present status and
               RD, Höfler H, Höhler T, Hölscher AH, Horneber M, Hübner J, Izbicki   future perspectives. Gastric Cancer 2007;10:197-204.
               JR, Jakobs R, Jenssen C, Kanzler S, Keller M, Kiesslich R, Klautke   78.  Katsuragi K, Yashiro M, Sawada T, Osaka H, Ohira M, Hirakawa K.
                           Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ September 18, 2016     373
   378   379   380   381   382   383   384   385   386   387   388